Key result
Protein C concentrate plus anticoagulation controls recurrent thrombosis in severe homozygous protein C deficiency.
Why the study?
Protein C deficiency is a rare autosomal recessive disorder associated with a high risk of thromboembolic complications, presenting significant management challenges.
Case Report (n=1)
No
This case highlights the complexities of managing severe protein C deficiency, emphasizing the need for individualized, long-term combination therapies with protein C concentrate and anticoagulation.
Answers are grounded in this paper and cite their sources.
Severe protein C deficiency management may require protein C concentrate plus anticoagulation after FFP anaphylaxis; leaves open need for improved long-term therapies.
Protein C deficiency is a rare autosomal recessive disorder associated with a high risk of thromboembolic complications. This case report describes the challenges in managing a 23-year-old woman with severe homozygous protein C type 1 deficiency diagnosed since early infancy. Her medical history included misdiagnosed cellulitis, recurrent thrombosis, and permanent vision loss in one eye. The laboratory workup confirmed a diagnosis of severe protein C deficiency. Management involved a combination of fresh frozen plasma (FFP), protein C concentrate, warfarin, and heparin, with ongoing challenges due to recurrent thrombosis and anaphylaxis to FFP. This case highlights the challenges in the diagnosis and management of severe protein C deficiency. Although current treatment options provide partial control, further research is crucial to develop safer and more effective therapies to improve long-term outcomes for affected patients.
No takes yet. Share an insight, caveat, or question.
Almatter et al. (2024) conducted a case report in Severe homozygous protein C type 1 deficiency (n=1). Protein C replacement and anticoagulation was evaluated on Clinical course and management of recurrent thrombosis. Management of severe homozygous protein C deficiency is challenging and required a combination of protein C concentrate and anticoagulation to stabilize recurrent thrombosis after anaphylaxis to fresh frozen plasma.
Synapse has enriched 10 related papers. Consider them for comparative context: